Research priorities

ONCOLOGY

oncologie.jpg

The discovery and development of Innovative cancer treatments is the group’s primary focus for pharmaceutical research. Year in, year out, onco-hematology attracts no less than 50% of our R&D spendings. We are therefore the second French pharmaceutical company in terms of anti-cancer research.

NEUROPSYCHIATRY

neuropsychiatrie.jpg

Our neuropsychiatry research is based on new therapeutic solutions for the treatment of schizophrenia, bipolar disorders, neurodegenerative diseases, depressive disorders, and chronic pain.

DERMATOLOGY

dermatologie.jpg

Dermatology is a meeting point between our pharmaceutical and dermo-cosmetical R&D teams. It is the cornerstone that captures our desire to be present from “health to beauty”. On the pharmaceutical front, our efforts today focus mainly on infantile hemangioma and onco-dermatological diseases.